Co-Diagnostics, Inc. is trading at $7.42 (up 19.7%) today, rebounding after a sharp decline triggered by a large resale registration filing.
- Shares fell approximately 21% on June 1, 2026, after the SEC declared an S-3 resale registration effective for up to 4.94 million shares and warrants from a May private placement.
- The previous selloff was driven by investor concerns over potential share dilution and increased supply hitting the market.
- Today's upward movement represents a partial snapback as the stock remains highly volatile following the resolution of the registration overhang.